25 September 2024
Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.
Diageo Finance plc
Post-stabilisation Period Announcement
Further to the pre-stabilisation period announcement dated 27 August 2024, Morgan Stanley & Co. International plc acting as Coordinating Stabilisation (contact: Morgan Stanley Debt Syndicate - Daniel Shane; telephone: +44 20 7677-7070) hereby gives notice that no stabilisation (within the meaning of Article 3.2(d) of the EU Market Abuse Regulation (596/2014), including as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018) was undertaken by the Stabilisation Manager(s) named below in relation to the offer of the following securities.
Securities
| Issuer: | Diageo Finance plc |
| Guarantor(s) (if any): | Diageo plc |
| Aggregate nominal amount: | 2031 Notes - EUR 700,000,000 2035 Notes - EUR 700,000,000 2044 Notes - EUR 500,000,000 |
| Description: | Senior Unsecured Notes due 2031 (the "2031 Notes") Senior Unsecured Notes due 2035 (the "2035 Notes") Senior Unsecured Notes due 2044 (the "2044 Notes") |
| ISIN: | 2031 Notes - XS2833390920 2035 Notes - XS2833391498 2044 Notes - XS2833394161 |
| Offer price: | 2031 Notes - 100% 2035 Notes - 99.431% 2044 Notes - 98.828% |
Stabilisation
| Stabilisation Manager(s): | Morgan Stanley & Co. International plc Banco Santander, S.A. Citigroup Global Markets Limited NatWest Markets Plc |
This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.
This announcement is not an offer of securities for sale into the United States. The securities referred to above have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There has not been and will not be a public offer of the securities in the United States.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
